Ghalwash A. A. et al. The gut microbiota metabolite trimethylamine-N-oxide in children with β-thalassemia: potential implication for iron-induced renal tubular dysfunction. Pediatr Res. https://doi.org/10.1038/s41390-024-03639-w (2024).

Zahran, A. M. et al. Could the crosstalk between myeloid-derived-suppressor cells and regulatory T cells have a role in Beta-Thalassemia? J. Hematol. 12, 161–169 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nonejuie, P. et al. Differential gut microbiota composition in β-Thalassemia patients and its correlation with iron overload. Sci. Rep. 14, 23858 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhen, J. et al. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases. Front Endocrinol. 14, 1085041 (2023).

Article  Google Scholar 

Velasquez, M. T. et al. Trimethylamine N-Oxide: The Good, the Bad and the Unknown. Toxins 8, 326 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Craciun, S. & Balskus, E. P. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc. Natl Acad. Sci. USA 109, 21307–21312 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou, S. et al. Gut-Flora-dependent Metabolite Trimethylamine-N-Oxide promotes Atherosclerosis-associated inflammation responses by indirect ROS stimulation and signaling involving AMPK and SIRT1. Nutrients 14, 3338 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu, C. et al. Novel role of the SIRT1 in endocrine and metabolic diseases. Int J. Biol. Sci. 19, 484–501 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei, L. et al. The SIRT1-HMGB1 axis: Therapeutic potential to ameliorate inflammatory responses and tumor occurrence. Front. Cell Dev. Biol. 10, 986511 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Singh, G. B. et al. High Mobility Group Box 1 Mediates TMAO-induced endothelial dysfunction. Int. J. Mol. Sci. 20, 3570 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin Q. et al. Sirtuins in kidney diseases: potential mechanism and therapeutic targets. Cell Commun. Signal 22, 1–15 (2024).